Sureda, A., Pavlovsky, A., Haidar, D., Kristo, F., Stache, V., & Zomas, A. (2025). Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A systematic review and meta-analysis.
Citación estilo ChicagoSureda, Anna, Astrid Pavlovsky, Dalah Haidar, Fjoralba Kristo, Vanessa Stache, y Athanasios Zomas. Real-world Outcomes of Brentuximab Vedotin As Consolidation Therapy After Autologous Stem Cell Transplantation in Relapsed/refractory Hodgkin Lymphoma: A Systematic Review and Meta-analysis. 2025.
Cita MLASureda, Anna, et al. Real-world Outcomes of Brentuximab Vedotin As Consolidation Therapy After Autologous Stem Cell Transplantation in Relapsed/refractory Hodgkin Lymphoma: A Systematic Review and Meta-analysis. 2025.